We are pleased to announce that the Icahn School of Medicine at Mount Sinai Biomedical Engineering and Imaging Institute/Department of Diagnostic, Molecular and Interventional Radiology has been ranked 19thin National Institutes of Health (NIH) funding with $7,954,013 in 2018. The department has steadily been increasing its ranking over the past decade, having achieved a ranking of 20thlast year for the first time.
Leading the list of investigators is the director of the Translational and Molecular Imaging Institute (TMII) Dr. Zahi Fayad. Dr. Fayad also rose one place in the ranking of NIH funding of faculty in radiology/imaging researchacross the country. In 2018 Dr. Fayad ranked4thin the nation (up from 5thin 2017) with $4,230,639 in funding. The department was further bolstered by the following TMII faculty and post-doctoral fellow; Dr. Willem Mulder ($2,201,097), Dr Priti Balchandani ($811,481) Dr. Bachir Taouli ($513,907), Dr. Alan Seifert ($133,855), and Dr. Octavia Bane ($63,034).NIH funding has grown increasingly competitive and serves as an indication of the strength and innovation of a department and its faculty.
The Icahn School of Medicine at Mount Sinai Department of Diagnostic, Molecular and Interventional Radiology continues to support and encourage faculty in their research efforts to advance medical imaging from signal acquisition to improved diagnosis and treatment outcomes. Note: Rankings are compiled by the independentBlue Ridge Institute for Medical Researchbased on the most current NIH data.
Pictured above: Biomedical Engineering and Imaging Institute with director, Zahi Fayad (front, center)